Graves' Disease Forecast in 23 Major Markets 2017-2027 - Research and Markets
Monday, 02 October 2017 01:06
Oct. 2, 2017 10:33 UTC

Graves' Disease Forecast in 23 Major Markets 2017-2027 - Research and Markets

DUBLIN--(BUSINESS WIRE)-- The "Graves' Disease Forecast in 23 Major Markets 2017-2027" report has been added to Research and Markets' offering.

Graves' disease is an autoimmune disease of the thyroid gland, in which the thyroid attacked by the body's own defence mechanisms becomes enlarged and produces increased amount of hormones, causing hyperthyroidism. The condition induces signs and symptoms that seriously affect the patient's quality of life, everyday activities and ability to work.

This report provides the current prevalent population for Graves' disease across 23 Major Markets (USA, Canada, France, Germany, Italy, Spain, UK, Poland, The Netherlands, Norway, Sweden, Austria, Denmark, Iceland, Switzerland, Turkey, Japan, China, South Korea, India, Australia, Brazil, Mexico) split by gender and 5-year age cohort. Along with the current prevalence, the report also contains a disease overview of the risk factors, disease diagnosis and prognosis along with specific variations by geography and ethnicity.

Providing a value-added level of insight from the analysis team, several of the main symptoms and co-morbidities of Graves' disease have been quantified and presented alongside the overall prevalence figures. These sub-populations within the main disease are also included at a country level across the 10-year forecast snapshot.

The quantified symptoms and co-morbidities for Graves' disease include:

  • Graves' Ophthalmopathy
  • Acropachy
  • Thyroid dermopathy

Key Topics Covered:

1. Introduction

2. Cause of the Disease

3. Risk Factors & Prevention

4. Diagnosis of the Disease

5. Variation by Geography/Ethnicity

6. Disease Prognosis & Clinical Course

7. Key Comorbid Conditions / Features Associated With the Disease

8. Methodology for Quantification of Patient Numbers

9. Top-Line Prevalence for Graves' Disease

10. Features of Graves' Disease Patients

11. Comorbid Conditions of Graves' Disease Patients

12. Abbreviations Used in the Report

13. Other Publications

14. Patient-Based Databases

15. Patient-Based Offering

16. Online Pricing Data & Platforms

17. References

18. Appendix

For more information about this report visit


Research and Markets
Laura Wood, Senior Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Endocrine and Metabolic Disorders Drugs

Source: Research and Markets

BiomedReports is not paid or compensated by newswires to disseminate or report news and developments about publicly traded companies, but may from time to time receive compensation for advertising, data, analytics and investor relation services from various entities and firms. Full disclosures should be read in the 'About Us Section'.

Add this page to your favorite Social Bookmarking websites
Digg! Reddit!! Mixx! Google! Live! Facebook! Technorati! StumbleUpon! MySpace! Yahoo!